Lexaria Bioscience's DehydraTECH licensee Cannadips expands internationally

• Lexaria Bioscience (NASDAQ:LEXX) said Thursday its DehydraTECH licensee Boldt Runners, which owns Cannadips, expanded manufacturing deals to include Europe, Japan and South Africa.
• Cannadips CBD dip pouch, which is sold in over 6.5K stores across the U.S. and through DTC online sales, has LEXX's DehydraTECH enhancement technology inside every tin.

Comments

[Dehydratech]

Bevnology has advanced capabilities that support best-in-class beverage formulations and, together with Lexaria’s superior technology, could make industry-leading beverage products a reality for many brands. Lexaria’s DehydraTECHTM-CBD nanoemulsification formulation and processing techniques exhibited exceptional stability one year after production with less than 1% variability in CBD potency in fractions sampled from the top, middle and bottom of the beverage formulation without physical mixing or agitation; and, CBD content was verified at 93.4% of target potency and also evidenced excellent microbial purity after 12 months.

The latest stability testing occurred 25 months after originally bottling, with slightly higher variability but still retaining an average 78% of originally formulated CBD. As well, the microbiologic purity and cleanliness of the product exceeded all requirements 25 months after bottling.

[Uselessphoneguy]

Dont be surprised when MO scoops up the rest of LEXX after they create their new nicotine and rides the royalties/profits to Dividened Aristocrat status. Maybe LEXX ends up helping CRON as well? Long LEXX, OILFF, CGC, CRON

[OneStrawRevolutionFarming2023]

This might be an example of HOW potentially OFF the MBAers are:

WHY not just put a small bud of CBD flower in between the cheek and gums

instead of a processed Cannadips =

make zero sense :-(

[Cannabyss]

@DualRootZoneAquaponics2022 DehydraTECH is far more efficient than CBD by itself. Head on over to Lexaria's website and check out all the CBD studies they've had done by independent researchers. They don't have patents for nothing!

[OneStrawRevolutionFarming2023]

@Cannabyss Fair enough and thank you :-)

Bioavailability and efficiency and ONSET are NOT NECESSARY

because we titrate cannabis/hemp inputs 24/7

and do so in

POLYCULTURE COMBINATIONS

IN BALANCED

(some energizing inputs and some relaxing inputs to "meet in the middle")

LAYERS

(EACH delivery system can add a layer even if the constituent inputs are the SAME:

combustion/smoke;
convection/vape;
oils;
"live" resin/rosin;
11-hydroxy,
RSO/FSO:

MANY SMALL inputs like a SALAD BAR) =

we don't do MONOCULTURE medicine with botanical medicine :-)

CBD and the efficiency of its delivery means almost nothing for cannabis patients

because we overlap

SO MANY, MANY FLOWERS/TYPES OF WELLNESS INPUTS

that the MEDICINE KNOWS WHERE TO GO AND WHAT TO DO :-)

Investors who are chasing a way to input cannabis/hemp are chasing folly

because we already have NO ISSUES WITH TITRATION :-)

Why chase what is NOT needed :-)

MEDICINE is changing to

WHOLE PLANT

and no more ridiculous searches for

"MAGIC BULLETS" and MONOCULTURE patented synthetics :-)

It's going to WHOLE PLANT, POLYCULTURE, Hoss :-)

No more fractionalizing things with botanical medicines :-)

[Cannabyss]

@DualRootZoneAquaponics2022 Onset is important for when you need immediate relief or results. Lexaria has shown faster onsets with a great many different API's. I'm not a chemist or pharmacist but it makes sense to me that almost instantaneous pain relief would be better than waiting half and hour or having your Viagra perk you up in the heat of the moment rather than after you fall asleep! LEXX is also working with Nicotine to create some NRT's for tobacco companies, hopefully to get folks away from the dangers of combustion and vaping. Nothing wrong with a little technology boost. It's like saying you might as well walk ten miles to the store because you'll get there eventually and with less damage to the environment. People want immediacy.

[Cannabyss]

Royalties piling up... :>)

[newfruit]

@Cannabyss I'd love to see some financial updates on how things are playing out.

[Cannabyss]

@newfruit This model of licensing to an endless stream of incoming businesses is getting better all the time. Love it.

[newfruit]

@Cannabyss Agreed, but I thought the reverse split was a huge mistake so while I don't question the science I do question how savvy management is in making deals.

I'm looking forward to the hypertension reports coming soon. Do you know when?